Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amarin Corp ADR (NQ: AMRN ) 0.5801 +0.0101 (+1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amarin Corp ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Amarin Shareholders Invited to Webcast with Board and Management Team February 13, 2023 From Amarin Corporation plc Via GlobeNewswire Sarissa Capital Does Not Believe Amarin Cares About Shareholders February 09, 2023 From Sarissa Capital Management LP Via Business Wire Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals February 09, 2023 From Amarin Corporation plc Via GlobeNewswire Sarissa Capital Highlights Amarin’s Inaccurate and Misleading Statements February 07, 2023 From Sarissa Capital Management LP Via Business Wire Why Amarin Stock Tumbled This Week January 20, 2023 Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders. Via The Motley Fool Why Amarin Stock Was a Winner Today November 15, 2022 The product most readily identified with the company will soon hit pharmacy shelves in Australia. Via The Motley Fool BP, Hertz Global, Take-Two Interactive Software And Other Big Stocks Moving Higher On Tuesday February 07, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts February 06, 2023 Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card From Amarin Corporation plc Via GlobeNewswire Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin February 03, 2023 From Sarissa Capital Management LP Via Business Wire Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership February 02, 2023 From Amarin Corporation plc Via GlobeNewswire Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders February 01, 2023 From Sarissa Capital Management LP Via Business Wire Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders January 31, 2023 From Amarin Corporation plc Via GlobeNewswire Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand January 27, 2023 Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 From Amarin Corporation plc Via GlobeNewswire Amarin to Present at SVB Securities Global Biopharma Conference January 27, 2023 From Amarin Corporation plc Via GlobeNewswire 3 Penny Stocks to Sell in January Before They Peter Out January 19, 2023 January has brought a major rally for penny stocks, but these three are likely to see their recent rallies evaporate in the coming weeks. Via InvestorPlace Amarin Calls Activist Investor, Largest Shareholder Sarissa's Statement 'Inaccurate, Misleading' January 19, 2023 Amarin Corporation Plc (NASDAQ: AMRN) reacted to its largest shareholder, Sarissa Capital Management, which said Amarin's recent board refreshment put "no shareholder representatives on the board." Via Benzinga Amarin Responds to Inaccurate and Misleading Statement by Sarissa January 19, 2023 From Amarin Corporation plc Via GlobeNewswire Sarissa Capital Calls Out Amarin’s Sham Board Refreshment January 18, 2023 From Sarissa Capital Management LP Via Business Wire Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders January 11, 2023 Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management From Amarin Corporation plc Via GlobeNewswire Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 10, 2023 Gainers Via Benzinga Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen January 10, 2023 From Sarissa Capital Management LP Via Business Wire Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023 January 10, 2023 From Amarin Corporation plc Via GlobeNewswire Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP January 10, 2023 From Amarin Corporation plc Via GlobeNewswire Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday January 06, 2023 Via Benzinga Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 06, 2023 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. Via Benzinga Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference December 14, 2022 From Amarin Corporation plc Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 January 06, 2023 Via Benzinga Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland December 07, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia November 15, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin to Present at Jefferies London Healthcare Conference November 09, 2022 From Amarin Corporation plc Via GlobeNewswire < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.